The Latest from our Blog

If you have seen anything from Maternova in the last few weeks, you have probably seen that we launched a line of fashionable, low-cost clothing embedded with nanotechnology to protect against mosquitoes. This was the result of months of brainstorming, researching, and testing different Zika solutions. It is clear why we would choose to get involved with the Zika response – Zika is a huge threat to pregnant women and their unborn babies, as it has been linked with severe birth defects. However, a clothing line is not the most obvious solution. If you are wondering why Maternova is tackling Zika with protective apparel, this is the article for you. Reason #1: Girls and women need multiple forms of protection against Zika
We have recently stumbled across an innovative aid to pregnant refugees that we could not keep to ourselves: an app called HaBaby. While maternal health has been of constant importance in the sphere of women’s rights, the topics and risks within maternal health evolve with the evolving world. This evolution means different populations are at increased risk for poor maternal health outcomes. Today, the staggering number of displaced persons and refugees is a huge population lacking sufficient maternal and newborn health resources. According to the United Nations High Commissioner for Refugees, there are currently 65.3 million forcibly displaced people worldwide, 21.3 million of who are refugees.
Sexually Transmitted Infections are harmful in across populations, but can have especially devastating effects during pregnancy. Screening is essential during the first trimester for what we have identified as the "Big 5 STIs": chlamydia, gonorrhea, syphilis, HIV, and Hepatitis B. The unique effects of each of these diseases on pregnancy will be explained below. Chlamydia Pregnant women with chlamydia hold a higher risk for birth complications. These include miscarriage, premature birth, and stillbirth. The disease can also be transmitted vertically during birth. Treatment for chlamydia is approved in pregnant women, and treatment before delivery erases the risk of transmission.
0 COMMENTS pregnancy STI STI screening 
We often do not think about what we cannot see, but in some cases we do not think about what we can see, and more importantly WHY we can see – power. It is no secret that the world is unequal. Most people are aware of at least some of these inequalities; for instance, almost everyone knows that the global burden of disease falls harder in Sub-Saharan Africa than Western Europe. Some inequalities, however, are less obvious and less discussed. Access to power is trivial in most developed countries, yet remains a major barrier to development in many impoverished nations.
An essential component of working in the maternal and neonatal health field is staying up to date on the rapidly evolving research. We do this through a variety of outlets; social media is a vital tool, and press releases or news stories are always useful sources. Another way for us to stay informed is by attending talks by experts in the field. This is how we found out about recent research on the adverse birth outcomes of ARV use during pregnancy.
Syndicate content